These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 1729881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 3. New developments in thrombolytic therapy.
    Collen DC, Gold HK.
    Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER.
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
    Grines CL, Nissen SE, Booth DC, Gurley JC, Chelliah N, Wolf R, Blankenship J, Branco MC, Bennett K, DeMaria AN.
    Circulation; 1991 Aug; 84(2):540-9. PubMed ID: 1907228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 15. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS, Lundergan CF, van den Brand M, Boland J, Thompson MA, Machecourt J, Py A, Pilcher GS, Fink CA, Burton JR.
    J Am Coll Cardiol; 1994 Nov 15; 24(6):1439-44. PubMed ID: 7930273
    [Abstract] [Full Text] [Related]

  • 16. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW, Kowalchuk GJ, Weaver WD, Loscalzo J, Sassower M, Manzo K, Byrnes C, Muller JE, Gurewich V.
    J Am Coll Cardiol; 1995 Aug 15; 26(2):374-9. PubMed ID: 7608437
    [Abstract] [Full Text] [Related]

  • 17. Thrombolytic therapy for myocardial ischemia and infarction.
    Rapaport E.
    Ann Epidemiol; 1992 Jul 15; 2(4):543-8. PubMed ID: 1342305
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.